ANCA-associated vasculitis trials in Austria

In Austria 5 Also abroad 97

5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
Where
Innsbruck
Age
6 years and over
People
230 worldwide
Run by
AstraZeneca
See details and how to joinNCT07444567
Phase 3Taking people
ROSY-F: Roll-over Study for Participants Who Have Completed a Previous Clinical Study with Benralizumab (Fasenra) and Benefit from Continued Treatment
Where
Innsbruck
People
94 worldwide
Run by
AstraZeneca AB
See details and how to join2025-523307-29-00 · EU 2025-523307-29-00
Phase 4Taking people
Discontinuation of rituximab compared with rituximab maintenance in ANCA-associated vasculitis – a randomized non-blinded controlled trial (DISRITUX)
Where
DO NOT EDIT
Age
18 years and over
People
130 worldwide
Run by
Region Oestergoetland
See details and how to join2023-508398-10-00 · EU 2023-508398-10-00
Phase 4Taking people
EFFECT OF ONCE VS TWICE DAILY ADMINISTRATION OF CORTICOSTEROIDS ON BLOOD GLUCOSE IN PATIENTS WITH ANCA-VASCULITIS MEASURED BY CONTINUOUS BLOOD GLUCOSE MONITORING - A PILOT STUDY
Where
Graz
Age
18 years and over
People
10
Run by
Medical University Of Graz
See details and how to join2024-516141-39-00 · EU 2024-516141-39-00
No phaseTaking people
Prospective Registry of Eosinophilia With Respiratory Manifestations With Translational Research Identifying and Characterizing Eosinophils
Where
Innsbruck
Age
18 years and over
People
300
Run by
Medical University Innsbruck
See details and how to joinNCT04538937